Literature DB >> 2227130

Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants.

P C Butler1, E J Kryshak, W F Schwenk, M W Haymond, R A Rizza.   

Abstract

It is well established that patients with non-insulin-dependent diabetes mellitus (NIDDM) are resistant to insulin. However, the contribution of hepatic and extrahepatic tissues to insulin resistance remains controversial. The uncertainty may be at least in part due to errors introduced by the unknowing use in previous studies of impure isotopes to measure glucose turnover. To determine hepatic and extrahepatic responses to insulin in the absence of these errors, steady-state glucose turnover was measured simultaneously with [6-3H]- and [6-14C]glucose during sequential 5- and 4-h infusions of insulin at rates of 0.4 and 10 mU.kg-1.min-1 in diabetic and nondiabetic subjects. At low insulin concentrations, [6-3H]- and [6-14C]glucose gave similar estimates of glucose turnover. Hepatic glucose release was equal to but not below zero in the nondiabetic subjects, but persistent glucose release (P less than 0.001) and decreased glucose uptake (P less than 0.001) was observed in the diabetic patients. At high insulin concentrations, both isotopes underestimated glucose turnover during the 1st h after initiation of the high-dose insulin infusion. More time (P less than 0.05) was required to reachieve steady state in NIDDM than nondiabetic subjects. At steady state, [6-3H]- but not [6-14C]glucose systematically underestimated (P less than 0.05) glucose turnover in both groups due to the presence of a tritiated nonglucose contaminant. The percentage of radioactivity in plasma due to tritiated contaminants was linearly related to turnover.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227130     DOI: 10.2337/diab.39.2.217

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.

Authors:  D Turk; A Alzaid; S Dinneen; K S Nair; R Rizza
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

3.  Role of pregnane X receptor in obesity and glucose homeostasis in male mice.

Authors:  Krisstonia Spruiell; Ricardo M Richardson; John M Cullen; Emmanuel M Awumey; Frank J Gonzalez; Maxwell A Gyamfi
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

4.  Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  D P Rooney; R D Neely; O Beatty; N P Bell; B Sheridan; A B Atkinson; E R Trimble; P M Bell
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

5.  Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production.

Authors:  L Rossetti; M Hu
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus.

Authors:  N Cohen; M Halberstam; P Shlimovich; C J Chang; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

7.  Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.

Authors:  A S Petrides; L C Groop; C A Riely; R A DeFronzo
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

8.  Decreased protein catabolism after exercise in subjects with IDDM.

Authors:  J T Devlin; A Scrimgeour; I Brodsky; S Fuller
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.